Zymergen Inc, based in Emeryville, CA, is a leading biotechnology company specializing in the development of innovative solutions for various industries. With a focus on biopharmaceuticals, industrial biotechnology, and agriculture, Zymergen offers a wide range of services and products, including RNA services, gene therapy services, enzymes, proteins, natural products, and fermentation scale-up. The company's platform, known as Foundry Codebase, combines automation and software capabilities to drive advancements in biological engineering. Zymergen recently completed its acquisition by Ginkgo, a move that is expected to further enhance its capabilities and open up new opportunities for partnerships and product development.
As a result of the acquisition, Zymergen's world-class team has joined Ginkgo, bringing their expertise and diverse array of product concepts to the table. The merger agreement, which was finalized in 2022, resulted in Zymergen stockholders receiving Ginkgo Class A common stock. With a strong focus on innovation and growth, Zymergen and Ginkgo are poised to continue making significant contributions to the biotechnology industry.
Generated from the website